Zenflow
Company Overview
Zenflow, based in South San Francisco, CA, operates in the healthcare industry, specifically within the medical devices sub-sector. The company was founded out of the Stanford Byers Center for Biodesign and has a team of 18 members. Zenflow focuses on developing disease-modifying therapies for benign prostatic hyperplasia (BPH). The company's flagship product is the Zenflow Spring System, which provides symptom relief for BPH through a minimally invasive procedure.
Zenflow Spring System
The Zenflow Spring System is a small implant designed to provide quick and long-lasting relief from benign prostatic hyperplasia (BPH) symptoms. The device is delivered through a simple procedure performed in a urologist's office. Clinical studies have shown that most patients experience symptom relief and fully recover from the procedure within hours. The Zenflow Spring System has garnered attention at notable events such as the AUA and EAU 2023 Meetings and was featured in a Urology Times article for its promise in BPH treatment.
Clinical Trials and Research
Zenflow launched a pivotal clinical trial for the minimally invasive Spring® Treatment for enlarged prostate symptoms on October 4, 2021. The promising clinical study results were featured at the AUA 2021 Meeting. These trials and studies consistently demonstrate the efficacy and rapid recovery associated with the Zenflow Spring System, making it a notable innovation in BPH treatment.
Leadership and Recognition
Shreya Mehta, Zenflow's CTO and Founder, has been recognized as a Healthtech Leader of the Month by the UCSF Rosenman Institute. CEO Susan Stimson was featured in a DeviceTalks Podcast discussing Zenflow's contributions to urology treatment. The company has also been highlighted in various media outlets, including a Forbes article recognizing it as among 50 women-led startups excelling in tech, and a MedTech Stories Podcast with Shreya Mehta.
Accolades and Contributions
Zenflow participated in the Stanford Byers Center for Biodesign program, which has impacted over a million patients. In 2015, the company was a semi-finalist in the Medtech Innovator competition. Zenflow's innovative work and contributions to urology have been recognized in multiple industry forums and publications, establishing its role in advancing medical device technology for BPH treatment.
Zenflow Search Occurrences
Showing 1-10 of 16 searches